The largest database of trusted experimental protocols

Prl sv40 renilla luciferase vector

Manufactured by Promega
Sourced in United States

The PRL-SV40 Renilla luciferase vector is a plasmid that expresses the Renilla luciferase reporter gene under the control of the SV40 early enhancer/promoter. Renilla luciferase is an enzyme that catalyzes the oxidation of coelenterazine, producing light. This vector can be used as a reporter to monitor gene expression or other cellular processes in transfected cells.

Automatically generated - may contain errors

16 protocols using prl sv40 renilla luciferase vector

1

CircDNM3OS and MORC2-miR-145-5p Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sequence of circDNM3OS or MORC2 3ʹ untranslated regions (UTR) complementary to miR-145-5p was predicted using the circInteractome or microT_CDS databases. The wild type (WT) sequences of circDNM3OS (circDNM3OS WT) and MORC2 3ʹ UTR (MORC2 3ʹUTR WT) and their mutant (MUT) sequences (circDNM3OS MUT and MORC2 3ʹUTR MUT) were synthesized and inserted into the pGL3 promoter vector (Promega), respectively. HuCCT1 and HuH28 cells were co-transfected with a luciferase reporter plasmid, pRL-SV40 (renilla luciferase vector) (Promega), and miR-145-5p or miR-NC using Lipofectamine 3000 reagent (Thermo Fisher Scientific). The luciferase activities in cell lysates were analyzed using the luciferase reporter assay kit (Promega).
+ Open protocol
+ Expand
2

Luciferase Assay for miRNA Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293S cells were seeded at 1 × 105 cells per well in 24-well plates the day prior to transfection. All transfections were carried out with Lipofectamine 2000 (Invitrogen), according to the manufacturer’s instructions. Cells were transfected with 80 ng of pMir-Report luciferase expression construct containing the 3′UTR of murine Hgf, 20 ng pRL-SV40 Renilla luciferase vector (Promega E2231) and 100 nM miR-26a mirVana miRNA mimic (Ambion, Assay MC10249) or miR-26b mimic (Ambion, Assay MC12899) or negative control miRNA mimic (Ambion 4464076). 24 h after transfection, luciferase activities were measured using the Dual-Luciferase Reporter Assay System (Promega) and normalized to Renilla luciferase activity. All experiments were performed in triplicate.
+ Open protocol
+ Expand
3

Investigating EcTRAF4 Regulation of IFN and NF-κB

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine the effects of EcTRAF4 on the activity of IFN and the nuclear factor-κB (NF-κB) promoter, luciferase plasmids, including those encoding zebrafish IFN3–Luc, human IFN-stimulated response element (ISRE)–Luc, and NF-κB–Luc (Promega, Madison, WI, USA), were used [37 (link),40 (link)]. In brief, GS cells were co-transfected with 200 ng of plasmid-encoding ISRE–Luc, IFN3–Luc, or NF-κB-Luc and 600 ng of pcDNA3.1-3 × HA or plasmid-encoding HA–EcTRAF4. A total of 50 ng of pRL-SV40 Renilla luciferase vector (Promega, Madison, WI, USA) was used as the internal control. The cells were harvested after 48 h to measure luciferase activities with the Dual-Luciferase® Reporter Assay System (Promega, Madison, WI, USA), according to the manufacturer’s instructions.
+ Open protocol
+ Expand
4

Allele-Specific Regulation of BACH2 Intron

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human DNA sequences (Coriell) with reference allele for rs72928038 (BACH2 intron) were cloned in forward orientation in the luciferase reporter vector pGL4.23 (Promega) using the primers: forward, AGCTAGGTACCACACTCAGTGGTTGGGGTTT, and reverse, TACCAGAGCTCCTGGATAGAGGTCCCAGTCG and the enzymes SacI and KpnI. Alternate allele plasmids were generated via site directed mutagenesis (Q5 SDM kit, New England Biolabs) using the following primers: forward, CGGATTTCCTaTAAGCTGATC, reverse, TCCCTATTTGTGTGTAATG.
Jurkat cells were maintained in culture at a concentration of 1x1005/mL-1x1006/mL. Approximately 0.5x1006 cells per replicate (3 replicates) were co-transfected with 500 ng of firefly luciferase vector containing either the reference or alternate allele or an empty pGL4.23 vector as a control, and 50 ng pRL-SV40 Renilla luciferase vector (Promega), using the Lipofectamine LTX reagent. Cells were collected 48 hours post transfection and assayed using the Dual-Luciferase Reporter system (Promega). Firefly activity was normalized to the Renilla activity and expressed as fold change compared to the luciferase activity of the empty vector (RLU). A two-sided t-test was used to compare the luciferase activity between the two alleles.
+ Open protocol
+ Expand
5

Quantification of ARG2 Promoter Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293 cells (2 × 105 cells) were seeded in 24-well plates, and 24 h later, 0.2 μg of recombinant pGL3 basic vector containing various lengths of the promoter region of ARG2 sequence and 25 ng of pRL-SV40 renilla luciferase vector (Promega) were cotransfected into cells using 4 μg Lipofectamine. After 6 h of incubation, the medium was replaced with the regular medium. After 24 h of transfection, luciferase activity was detected with use of a luminometer (TD-20/20 Turner Designs, Promega) with luciferase assay reagent (Promega) as previously described (Zhang et al., 2008b (link)).
+ Open protocol
+ Expand
6

Firefly Luciferase Reporter Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated at 5.104 cells/well in a 24-well plate. Transfections were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol. Antisense oligonucleotides were transfected as described in30 (link). For reporter assays, cells were treated with compound PA-1 before being transfected the following day with 100 ng/well of either pGL4-PM372 or pGL4-mut372 firefly luciferase reporter40 (link), mixed with 10 ng/well pRL-SV40 Renilla luciferase vector (Promega), used as a control for transfection efficiency. Firefly and Renilla luciferase activities were measured 48 h post-transfection using the Dual Luciferase Assay (Promega). Firefly luciferase activities were normalized for transfection efficiency by Renilla luciferase activity.
+ Open protocol
+ Expand
7

Cloning and Mutagenesis of NANOG Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
A pcDNA3.1 vector containing HIF-2α (EPAS1) (NCBI Reference Sequence: NM_001430.4) gene was kindly provided by Prof. David Russell from the Southwestern Medical Centre (Texas, USA). A region of 630 bp from −437 to +207 bp from the transcription start site of NANOG promoter was amplified with specific primers that contained XhoI and HINDIII restriction sites (NanogXho Forward 5′CTCGAGCGGCTGGTTTCAAACTCCTGA-3′ and NanogHINDIII Reverse 5′-TTCGAACCGGATGCTTCAAAGC-3′). The product was cloned into a TOPO vector (Invitrogen), and removed using XhoI/HINDIII restriction enzymes. The fragment was then cloned into the XhoI/HINDIII sites in a pGL3 Control vector (Promega). This construct was named pGL3-NANOG. Mutagenesis was performed using QuikChange site-directed mutagenesis (Stratagene) following the manufacturer’s procedure and using specific primers (Table S4 in File S1). Luciferase activity was measured using the dual luciferase reporter assay system (Promega) following the manufacturer’s instructions. Normalization was performed using PRL-SV40 Renilla luciferase vector (Promega).
+ Open protocol
+ Expand
8

EGR3 3'UTR Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The EGR3 wild-type (Wt) and mutant (Mt) 3′-UTR sequences were synthesized and sub-cloned into the psiCHECK luciferase reporter plasmid (Promega, Madison, WI, USA). 5-8F was seeded into a 12-well plate at a density of 5 × 106 and each recombinant luciferase reporter plasmid and the miR-483-5p mimic were co-transfected using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer’s instructions. The psiCHECK promoter vector was used as the control, and the pRL-SV40 Renilla luciferase vector (Promega) was used to normalize the activity of firefly luciferase. Twenty-four hours later, the luciferase activity in each well was detected using the Dual-Luciferase Reporter Assay System (Promega).
+ Open protocol
+ Expand
9

Luciferase Assay for miRNA Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293S cells were seeded at 1 × 105 cells per well in 24-well plates the day prior to transfection. All transfections were carried out with Lipofectamine 2000 (Invitrogen), according to the manufacturer’s instructions. Cells were transfected with 80 ng of pMir-Report luciferase expression construct containing the 3′UTR of murine Hgf, 20 ng pRL-SV40 Renilla luciferase vector (Promega E2231) and 100 nM miR-26a mirVana miRNA mimic (Ambion, Assay MC10249) or miR-26b mimic (Ambion, Assay MC12899) or negative control miRNA mimic (Ambion 4464076). 24 h after transfection, luciferase activities were measured using the Dual-Luciferase Reporter Assay System (Promega) and normalized to Renilla luciferase activity. All experiments were performed in triplicate.
+ Open protocol
+ Expand
10

Evaluating Wnt Signaling in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
NCI-N87 and NCI-N87R cells were transfected with pTA-Luc and TCF/LEF luciferase reporter vectors (Promega, Madison, WI, USA). We co-transfected NCI-N87 and NCI-N87R cells with the TopFlash firefly luciferase reporter vector and pRL-SV40-Renilla luciferase vector (Promega). Additionally, we incubated the cells for 72 h to detect the Wnt signaling pathway activity. The dual-luciferase reporter method (Promega) was used to determine the relative luciferase activity.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!